Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-06 Purchase |
2023-06-08 4:34 pm |
Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director |
10,097 | $3.6602 | $36,957 | 26,325 (Direct) |
View |
| 2022-05-18 Purchase |
2022-05-19 4:31 pm |
Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director |
50,000 | $0.71 | $35,500 | 318,580 (Direct) |
View |
| 2022-05-18 Purchase |
2022-05-19 4:30 pm |
Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO |
37,500 | $0.6433 | $24,124 | 303,616 (Indirect Direct) |
View |
| 2022-02-28 Sale |
2022-03-01 5:01 pm |
Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer |
36,000 | $1.73 | $62,280 | 47,331 (Indirect Direct) |
View |
| 2021-12-01 Sale |
2021-12-03 5:01 pm |
Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer |
27,500 | $3.96 | $108,900 | 19,502 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 5:34 pm |
Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer |
27,500 | $5 | $137,500 | 47,002 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-23 Option Award |
2023-08-24 9:47 pm |
N/A 2033-08-23 |
Aprea Therapeutics Inc. | APRE | BIZZARI JEAN-PIERRE Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-08 5:17 pm |
N/A 2033-05-05 |
Aprea Therapeutics Inc. | APRE | Gruia Gabriela Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-13 6:30 pm |
N/A 2033-03-09 |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
20,000 | $0 | 338,770 (Direct) |
View |
| 2022-08-23 Conversion |
2023-03-13 6:30 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
6,649,610 | $0 | 338,770 (Direct) |
View |
| 2023-02-27 Option Award |
2023-02-27 6:37 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr |
1,000 | $5.25 | 14,493 (Direct) |
View |
| 2023-01-30 Option Award |
2023-01-30 5:21 pm |
N/A 2033-01-30 |
Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin. Fin&Acctg. Off |
809,637 | $0 | 809,637 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:06 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director |
35,570 | $0 | 354,150 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:06 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Director |
80,000 | $0 | 317,846 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:05 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | Peters Richard Director |
35,570 | $0 | 40,180 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:04 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | Pamukcu Rifat Director |
35,570 | $0 | 47,736 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:04 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Operating Officer |
60,000 | $0 | 81,462 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:03 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | HENNEMAN JOHN B III Director |
35,570 | $0 | 45,180 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:02 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | Grissinger Michael Director |
35,570 | $0 | 35,570 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:01 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO |
250,000 | $0 | 479,014 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:00 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | Duey Marc Director |
35,570 | $0 | 187,913 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:00 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer |
150,000 | $0 | 234,265 (Direct) |
View |
| 2022-06-03 Tax Withholding |
2022-06-07 5:05 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO |
65,770 | $0.805 | 237,846 (Direct) |
View |
| 2022-06-03 Tax Withholding |
2022-06-07 5:02 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer |
35,284 | $0.805 | 84,265 (Direct) |
View |
| 2022-06-03 Tax Withholding |
2022-06-07 5:01 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Operating Officer |
8,390 | $0.805 | 21,462 (Direct) |
View |
| 2022-06-03 Tax Withholding |
2022-06-07 5:00 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer |
32,667 | $0.805 | 57,564 (Direct) |
View |
Ownership |
2022-05-26 4:15 pm |
2022-05-16 2029-01-19 |
Aprea Therapeutics Inc. | APRE | Grissinger Michael Director |
0 | $0 | 72,638 (Direct) |
View |
Ownership |
2022-05-26 4:15 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Pamukcu Rifat Director |
0 | $0 | 317,274 (Direct) |
View |
Ownership |
2022-05-26 4:15 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Gilad Oren President |
0 | $0 | 884,678 (Direct) |
View |
Ownership |
2022-05-26 4:15 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Duey Marc Director |
0 | $0 | 605,627 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 5:03 pm |
N/A 2032-03-10 |
Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO |
527,800 | $0 | 693,816 (Direct) |
View |
| 2022-03-10 Tax Withholding |
2022-03-14 5:03 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer |
1,989 | $1.82 | 102,452 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 5:03 pm |
N/A 2032-03-10 |
Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer |
88,600 | $0 | 102,452 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 5:02 pm |
N/A 2032-03-10 |
Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer |
228,800 | $0 | 305,449 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 5:01 pm |
N/A 2032-03-10 |
Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer |
228,800 | $0 | 276,131 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 5:01 pm |
N/A 2032-03-10 |
Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer |
124,700 | $0 | 143,700 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:02 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO |
21,644 | $1.74 | 166,016 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:02 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer |
1,326 | $1.74 | 15,841 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:01 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer |
14,817 | $1.74 | 76,649 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-03 5:01 pm |
N/A 2027-02-16 |
Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer |
27,500 | $0 | 19,502 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-03 5:01 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer |
27,500 | $0.92 | 19,502 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 5:34 pm |
N/A 2026-09-14 |
Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer |
27,500 | $0 | 47,002 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 5:34 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer |
27,500 | $0.92 | 47,002 (Direct) |
View |